A Blinded, Randomized, Nonfasting, Placebo-Controlled Study in Healthy Adults to Evaluate Safety, Tolerability, and Pharmacokinetic Profiles of Multiple Ascending Doses of ABT-450 With Ritonavir.
Phase of Trial: Phase I
Latest Information Update: 28 Dec 2015
At a glance
- Drugs Paritaprevir (Primary) ; Ritonavir
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 28 Dec 2015 Results of pooled analysis from this and other phase I trial (see profile 42034), published in the British Journal of Clinical Pharmacology.
- 08 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2009 Actual patient number (38) added as reported by ClinicalTrials.gov.